LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Listă Acțiuni・Abbott Laboratories

Abbott Laboratories

Închisă

Sector Sănătate

113.86 0.79

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

113.55

Maxim

114.24

Indicatori cheie
By Trading Economics
Venit	77M 1.3B
Vânzări	420M 10B
P/E Medie Sector	32.37 103.001
EPS	1.14
Marjă de profit	12.543
Angajați	114,000
EBITDA	170M 2.6B

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+12.36 upside

Dividende
By Dow Jones
Următoarele câștiguri	16 oct. 2024
Data viitoare de dividende	13 nov. 2024
Următoarea dată ex-dividende	10 oct. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	197B
Deschiderea anterioară	113.07
Închiderea anterioară	113.86

Sentimentul știrilor

By Acuity

59%

41%

278 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

113.255 / 114.66 Suport & Rezistență

Abbott Laboratories Grafic

Știri relevante

29 iul. 2024, 10:30 UTC

Principalele dinamici ale pieței

Abbott Laboratories Shares Tumble on $495 Million Infant Formula Verdict

29 iul. 2024, 09:27 UTC

Principalele dinamici ale pieței

Reckitt Benckiser Shares Tumble on Abbott's Baby-Formula Litigation

18 iul. 2024, 12:21 UTC

Câștiguri

Abbott Labs Lifts FY24 Outlook After 2Q Sales Rise

29 iul. 2024, 10:15 UTC

Principalele dinamici ale pieței

Abbott Laboratories Shares Tumble on $495 Mln Infant Formula Verdict

29 iul. 2024, 08:50 UTC

Acțiuni populare

Stocks to Watch Monday: Coinbase, Abbott, McDonald's, Heineken -- WSJ

18 iul. 2024, 19:04 UTC

Market Talk

Câștiguri

Abbott CEO Warns of Health Crisis if Preterm Formula Pulled -- Market Talk

18 iul. 2024, 11:43 UTC

Câștiguri

Abbott Laboratories Earnings Top Views, Full-Year Guidance Raised -- IBD

18 iul. 2024, 11:34 UTC

Câștiguri

Abbott Labs Sees 3Q Adj EPS $1.18-Adj EPS $1.22 >ABT

18 iul. 2024, 11:34 UTC

Câștiguri

Abbott Labs Sees 3Q EPS 85c-EPS 89c >ABT

18 iul. 2024, 11:31 UTC

Câștiguri

Abbott Labs Narrows FY24 Organic Sales Growth View, Ex-COVID-19 Testing-Related Sales, to 9.5% to 10% >ABT

18 iul. 2024, 11:30 UTC

Câștiguri

Abbott Labs Sees FY Adj EPS $4.61-Adj EPS $4.71 >ABT

18 iul. 2024, 11:30 UTC

Câștiguri

Abbott Labs Sees FY EPS $3.30-EPS $3.40 >ABT

18 iul. 2024, 11:30 UTC

Câștiguri

Abbott Labs 2Q Organic Sales Growth Up 7.4% >ABT

18 iul. 2024, 11:30 UTC

Câștiguri

Abbott Labs 2Q Sales $10.38B >ABT

18 iul. 2024, 11:30 UTC

Câștiguri

Abbott Labs 2Q Adj EPS $1.14 >ABT

18 iul. 2024, 11:30 UTC

Câștiguri

Abbott Labs 2Q Net $1.3B >ABT

18 iul. 2024, 11:30 UTC

Câștiguri

Abbott Labs 2Q EPS 74c >ABT

18 iul. 2024, 11:30 UTC

Câștiguri

Abbott Raises Full-Yr Guidance

14 iul. 2024, 22:41 UTC

Câștiguri

Stocks Poised for Higher Open -- Barrons.com

12 iul. 2024, 23:29 UTC

Achiziții, Fuziuni, Preluări

BP Says Oil Demand Is Falling, While OPEC Says It's Rising. What Gives? -- Barrons.com

17 apr. 2024, 13:54 UTC

Câștiguri

Abbott Labs Stock Is Slipping After Earnings Beat. Here's Why. -- Barrons.com

17 apr. 2024, 12:41 UTC

Top știri

Câștiguri

Abbott Labs Stock Is Slipping. Disappointing Guidance Trumps a Strong Quarter. -- Barrons.com

17 apr. 2024, 11:52 UTC

Câștiguri

Abbott Labs Jumps, Retreats On Q1 Beat, Shy Guidance -- IBD

17 apr. 2024, 11:45 UTC

Câștiguri

Abbott Labs First-Quarter Results Top Estimates Amid Strong Medical Device Sales -- MarketWatch

17 apr. 2024, 11:32 UTC

Câștiguri

Abbott Labs Narrows 2024 Organic Sales Growth Ex-Covid-19 View to 8.5%-10% >ABT

17 apr. 2024, 11:30 UTC

Câștiguri

Abbott Labs 1Q Organic Sales for Underlying Base Business Rose 10.8% >ABT

17 apr. 2024, 11:30 UTC

Câștiguri

Abbott Raises Midpoint of Full-Year Guidance Ranges >ABT

17 apr. 2024, 11:30 UTC

Câștiguri

Abbott Labs Sees FY Adj EPS $4.55-Adj EPS $4.70 >ABT

17 apr. 2024, 11:30 UTC

Câștiguri

Abbott Labs 1Q Adj EPS 98c >ABT

17 apr. 2024, 11:30 UTC

Câștiguri

Abbott Labs 1Q EPS 70c >ABT

Comparație

Modificare preț

Abbott Laboratories Așteptări

Obiectiv de preț

By TipRanks

12.36% sus

Prognoză pe 12 luni

Medie 127.08 USD 12.36%

Maxim 143 USD

Minim 107 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAbbott Laboratories - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

14 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 14 analiști care au acordat evaluări ale acțiunilor Abbott Laboratories - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

113.255 / 114.66Suport & Rezistență

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

278 / 365 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Abbott Laboratories

Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.